BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 25934142)

  • 21. Efficacy of artesunate + sulphadoxine/pyrimethamine and artemether + lumefantrine and dhfr and dhps mutations in Somalia: evidence for updating the malaria treatment policy.
    Warsame M; Hassan AH; Hassan AM; Arale AM; Jibril AM; Mohamud SA; Barrette A; Muse AY; Yusuf FE; Nada RA; Amran JG
    Trop Med Int Health; 2017 Apr; 22(4):415-422. PubMed ID: 28151566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevalence and antifolate drug resistance profiles of Plasmodium falciparum in study participants randomized to discontinue or continue cotrimoxazole prophylaxis.
    Juma DW; Muiruri P; Yuhas K; John-Stewart G; Ottichilo R; Waitumbi J; Singa B; Polyak C; Kamau E
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007223. PubMed ID: 30897090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan.
    Ghanchi NK; Ursing J; Beg MA; Veiga MI; Jafri S; Mårtensson A
    Malar J; 2011 Jan; 10():18. PubMed ID: 21272384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haplotypes associated with resistance to sulfadoxine-pyrimethamine in Plasmodium falciparum in two malaria endemic locations in Colombia.
    Hernández DC; Guerra AP; Cucunubá ZM; Nicholls RS; Barrera SM
    Infect Genet Evol; 2013 Aug; 18():183-90. PubMed ID: 23714094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine among pregnant women receiving intermittent preventive treatment for malaria in Uganda.
    Mbonye AK; Birungi J; Yanow SK; Shokoples S; Malamba S; Alifrangis M; Magnussen P
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5475-82. PubMed ID: 26124154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased prevalence of pfdhfr and pfdhps mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Jazan Region, Southwestern Saudi Arabia: important implications for malaria treatment policy.
    Madkhali AM; Al-Mekhlafi HM; Atroosh WM; Ghzwani AH; Zain KA; Abdulhaq AA; Ghailan KY; Anwar AA; Eisa ZM
    Malar J; 2020 Dec; 19(1):446. PubMed ID: 33267841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increase in the prevalence of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso.
    Ruizendaal E; Tahita MC; Geskus RB; Versteeg I; Scott S; d'Alessandro U; Lompo P; Derra K; Traore-Coulibaly M; de Jong MD; Schallig HDFH; Tinto H; Mens PF
    Malar J; 2017 Apr; 16(1):179. PubMed ID: 28454537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of the dhfr and dhps Mutations among Pregnant Women in Rural Burkina Faso Five Years after the Introduction of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine.
    Tahita MC; Tinto H; Erhart A; Kazienga A; Fitzhenry R; VanOvermeir C; Rosanas-Urgell A; Ouedraogo JB; Guiguemde RT; Van Geertruyden JP; D'Alessandro U
    PLoS One; 2015; 10(9):e0137440. PubMed ID: 26368675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of specific Plasmodium falciparum mutations in resistance to amodiaquine and sulfadoxine-pyrimethamine in Burkina Faso.
    Dokomajilar C; Lankoande ZM; Dorsey G; Zongo I; Ouedraogo JB; Rosenthal PJ
    Am J Trop Med Hyg; 2006 Jul; 75(1):162-5. PubMed ID: 16837725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
    Bamaga OA; Mahdy MA; Lim YA
    Malar J; 2015 Dec; 14():516. PubMed ID: 26693691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in Tanzania.
    Baraka V; Ishengoma DS; Fransis F; Minja DT; Madebe RA; Ngatunga D; Van Geertruyden JP
    Malar J; 2015 Nov; 14():439. PubMed ID: 26542942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High multiple mutations of Plasmodium falciparum-resistant genotypes to sulphadoxine-pyrimethamine in Lagos, Nigeria.
    Quan H; Igbasi U; Oyibo W; Omilabu S; Chen SB; Shen HM; Okolie C; Chen JH; Zhou XN
    Infect Dis Poverty; 2020 Jul; 9(1):91. PubMed ID: 32653033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania.
    Matondo SI; Temba GS; Kavishe AA; Kauki JS; Kalinga A; van Zwetselaar M; Reyburn H; Kavishe RA
    Malar J; 2014 Apr; 13():152. PubMed ID: 24751352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi.
    Bwijo B; Kaneko A; Takechi M; Zungu IL; Moriyama Y; Lum JK; Tsukahara T; Mita T; Takahashi N; Bergqvist Y; Björkman A; Kobayakawa T
    Acta Trop; 2003 Mar; 85(3):363-73. PubMed ID: 12659974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistence of Sulfadoxine-Pyrimethamine Resistance Despite Reduction of Drug Pressure in Malawi.
    Artimovich E; Schneider K; Taylor TE; Kublin JG; Dzinjalamala FK; Escalante AA; Plowe CV; Laufer MK; Takala-Harrison S
    J Infect Dis; 2015 Sep; 212(5):694-701. PubMed ID: 25672905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High prevalence of sulfadoxine/pyrimethamine resistance alleles in Plasmodium falciparum parasites from Bangladesh.
    Marma AS; Mita T; Eto H; Tsukahara T; Sarker S; Endo H
    Parasitol Int; 2010 Jun; 59(2):178-82. PubMed ID: 20097306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergence of sulfadoxine-pyrimethamine resistance in Indian isolates of Plasmodium falciparum in the last two decades.
    Kumar A; Moirangthem R; Gahlawat SK; Chandra J; Gupta P; Valecha N; Anvikar A; Singh V
    Infect Genet Evol; 2015 Dec; 36():190-198. PubMed ID: 26319997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of molecular markers of sulfadoxine-pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan.
    Yaqoob A; Khattak AA; Nadeem MF; Fatima H; Mbambo G; Ouattara A; Adams M; Zeeshan N; Takala-Harrison S
    Malar J; 2018 Dec; 17(1):471. PubMed ID: 30558587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic polymorphisms associated with sulphadoxine-pyrimethamine drug resistance among Plasmodium falciparum field isolates in malaria endemic areas of Assam.
    Sharma J; Dutta P; Khan SA; Soni M; Dey D; Mahanta J
    J Postgrad Med; 2015; 61(1):9-14. PubMed ID: 25511211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulfadoxine-pyrimethamine susceptibilities and analysis of the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum isolates from Côte d'Ivoire.
    Djaman JA; Mazabraud A; Basco L
    Ann Trop Med Parasitol; 2007 Mar; 101(2):103-12. PubMed ID: 17316496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.